Global market for drugs used to treat liver disease to grow to $14.2 billion by 2016

In 2010, the global market for drugs used to treat liver disease was worth $12.4 billion. The estimated sales for 2011 were approximately $12 billion (excluding protease inhibitors) and are expected to rise at a compound annual growth rate (CAGR) of 3.3% to reach $14.2 billion by 2016.

Learn about the present and future strategies within the liver disease drug market, including market sizes, market leaders, market overview, and various other market factors, as well as the market for end users. Companies that manufacture and sell new and innovative liver disease-related drugs are profiled as well...

Use this report to:

• Gain an overview of the current and future characteristics of the global market for liver disease drugs, including the market for end users
• Learn about different categories of liver disease drugs and the various types of liver disease broken down by market shares belonging to leading manufacturers and/or suppliers
• Gain information regarding different liver disease drugs in response to an increasing need for new and innovative drug treatments
• Analyze the market leaders, regulatory environment, technology, market projections, and market shares of the liver disease drug industry.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

GLOBAL REVENUE FOR DRUGS USED TO TREAT LIVER DISEASES BY REGION, 2009-2016

($ MILLIONS)

Source: BCC Research